A. Ang

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

S. Choo, S. Tan, K. Ng, 2019, Asia-Pacific journal of clinical oncology.

Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center

S. Choo, S. Tan, K. Ng, 2020, Asia-Pacific journal of clinical oncology.

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma

S. Choo, S. Tan, K. Ng, 2021, Liver Cancer.

Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian center.

S. Choo, S. Tan, K. Ng, 2020 .

Nephrolithiasis: Approach to Diagnosis and Management

Amita Sharma, Andrea J.S. Ang, Ashley A Sharma, 2020, The Indian Journal of Pediatrics.

SO-39 Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100

T. Price, A. Hindoyan, T. Kurata, 2022, Annals of Oncology.

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

S. Choo, S. Tan, K. Ng, 2022, Asia-Pacific journal of clinical oncology.